Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function. (Q47567886)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Kisha Nandini Sivanathan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Darling M Rojas-Canales

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Ravi Krishnan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Shane T Grey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Patrick T Coates

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

23 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

2850-2863

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26037953%20AND%20SRC:MED&resulttype=core&format=json

Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow.

16 February 2020

cites work

1 reference

Mesenchymal stem cells as trophic mediators

21 January 2018

1 reference

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

21 January 2018

1 reference

Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

21 January 2018

1 reference

MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines.

21 January 2018

1 reference

More insight into mesenchymal stem cells and their effects inside the body

21 January 2018

1 reference

Role of mesenchymal stromal cells in solid organ transplantation

21 January 2018

1 reference

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.

21 January 2018

1 reference

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

21 January 2018

1 reference

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

21 January 2018

1 reference

Mesenchymal stem cells in kidney inflammation and repair

21 January 2018

1 reference

Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation

21 January 2018

1 reference

Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial

21 January 2018

1 reference

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation.

21 January 2018

1 reference

Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9

21 January 2018

1 reference

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell

21 January 2018

1 reference

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.

21 January 2018

1 reference

Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis

21 January 2018

1 reference

EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.

21 January 2018

1 reference

Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes

21 January 2018

1 reference

Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves

21 January 2018

1 reference

Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells

21 January 2018

1 reference

Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression

21 January 2018

1 reference

Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

21 January 2018

1 reference

The characterization and role of regulatory T cells in immune reactions

21 January 2018

1 reference

Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease

21 January 2018

1 reference

Regulatory T cells in autoimmmunity*.

21 January 2018

1 reference

Harnessing FOXP3+ regulatory T cells for transplantation tolerance.

21 January 2018

1 reference

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

21 January 2018

1 reference

Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially

21 January 2018

1 reference

Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis

21 January 2018

1 reference

Activated mesenchymal stem cells increase wound tensile strength in aged mouse model via macrophages

21 January 2018

1 reference

Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response

21 January 2018

1 reference

Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

IFN-γ and TNF-α synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFκB signaling.

21 January 2018

1 reference

IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand

21 January 2018

1 reference

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

IL-17 and FGF signaling involved in mouse mesenchymal stem cell proliferation.

21 January 2018

1 reference

Interleukin-17A: a T-cell-derived growth factor for murine and human mesenchymal stem cells

21 January 2018

1 reference

Interleukin-17 enhances immunosuppression by mesenchymal stem cells

21 January 2018

1 reference

Immunomodulatory properties of human periodontal ligament stem cells

21 January 2018

1 reference

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

The immune phenotype may relate to cancer development in kidney transplant recipients.

21 January 2018

1 reference

Inhibition of activation induced CD154 on CD4+ CD25- cells: a valid surrogate for human Treg suppressor function

21 January 2018

1 reference

IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling.

21 January 2018

1 reference

Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells.

21 January 2018

1 reference

Immunogenicity of allogeneic mesenchymal stem cells.

21 January 2018

1 reference

Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells

21 January 2018

1 reference

Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells

21 January 2018

1 reference

IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets

21 January 2018

1 reference

High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population

21 January 2018

1 reference

Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression

21 January 2018

1 reference

Essential role for CD103 in the T cell-mediated regulation of experimental colitis

21 January 2018

1 reference

Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells

21 January 2018

1 reference

Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells

21 January 2018

1 reference

Glucocorticoid-Induced TNF Receptor Family-Related Protein Ligand is Requisite for Optimal Functioning of Regulatory CD4(+) T Cells

21 January 2018

1 reference

Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg

21 January 2018

1 reference

Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta

21 January 2018

1 reference

Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis

21 January 2018

1 reference

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

21 January 2018

1 reference

Natural killer cells prime the responsiveness of autologous CD4+ T cells to CTLA4-Ig and interleukin-10 mediated inhibition in an allogeneic dendritic cell-mixed lymphocyte reaction

21 January 2018

1 reference